Jinrong Fu

Jinrong Fu

Auto-generated profile, based on publicly available information

Jinrong Fu

General Department, Children’s Hospital of Fudan University, Shanghai, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2021 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
LYLan Yang
Lan Yang
XXXueru Xie
Xueru Xie
ZTZikun Tu
Zikun Tu
JFJinrong Fu
Jinrong Fu
DXDamo Xu
Damo Xu
YZYufeng Zhou
Yufeng Zhou
The Coronavirus Disease 2019 (COVID-19) pandemic has become a global crisis and is more devastating than any other previous infectious disease. It has affected a significant proportion of the global population both physically and mentally, and destroyed businesses and societies. Current evidence suggested that immunopathology may be responsible for COVID-19 pathogenesis, including lymphopenia, neutrophilia, dysregulation of monocytes and macrophages, reduced or delayed type I interferon (IFN-I) response, antibody-dependent enhancement, and especially, cytokine storm (CS). The CS is characterized by hyperproduction of an array of pro-inflammatory cytokines and is closely associated with poor prognosis. These excessively secreted pro-inflammatory cytokines initiate different inflammatory signaling pathways via their receptors on immune and tissue cells, resulting in complicated medical symptoms including fever, capillary leak syndrome, disseminated intravascular coagulation, acute respiratory distress syndrome, and multiorgan failure, ultimately leading to death in the most severe cases. Therefore, it is clinically important to understand the initiation and signaling pathways of CS to develop more effective treatment strategies for COVID-19. Herein, we discuss the latest developments in the immunopathological characteristics of COVID-19 and focus on CS including the current research status of the different cytokines involved. We also discuss the induction, function, downstream signaling, and existing and potential interventions for targeting these cytokines or related signal pathways. We believe that a comprehensive understanding of CS in COVID-19 will help to develop better strategies to effectively control immunopathology in this disease and other infectious and inflammatory diseases.

13 November 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
XHXiao Han
Xiao Han
LLLijuan Liu
Lijuan Liu
SHSaihua Huang
Saihua Huang
WXWenfeng Xiao
Wenfeng Xiao
YGYajing Gao
Yajing Gao
YZYufeng Zhou
Yufeng Zhou
N6-methyladenosine (m6A), the most prevalent mRNA modification, has an important function in diverse biological processes. However, the involvement of m6A in allergic asthma and macrophage homeostasis remains largely unknown. Here we show that m6A methyltransferases METTL3 is expressed at a low level in monocyte-derived macrophages from childhood allergic asthma patients. Conditional knockout of Mettl3 in myeloid cells enhances Th2 cell response and aggravates allergic airway inflammation by facilitating M2 macrophage activation. Loss and gain functional studies confirm that METTL3 suppresses M2 macrophage activation partly through PI3K/AKT and JAK/STAT6 signaling. Mechanistically, m6A-sequencing shows that loss of METTL3 impairs the m6A-YTHDF3-dependent degradation of PTX3 mRNA, while higher PTX3 expression positively correlates with asthma severity through promoting M2 macrophage activation. Furthermore, the METTL3/YTHDF3-m6A/PTX3 interactions contribute to autophagy maturation in macrophages by modulating STX17 expression. Collectively, this study highlights the function of m6A in regulating macrophage homeostasis and identifies potential targets in controlling allergic asthma.

6 December 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
XHXiao Han
Xiao Han
SHSaihua Huang
Saihua Huang
PXPing Xue
Ping Xue
JFJinrong Fu
Jinrong Fu
LLLijuan Liu
Lijuan Liu
YZYufeng Zhou
Yufeng Zhou
PTPRE-AS1 deficiency aggravates pulmonary inflammation but reduces colitis severity by modulating M2 macrophage activation.

22 July 2021 in Cell Death & Differentiation
Verified
Journal Article
Closed access
PXPing Xue
Ping Xue
SHSaihua Huang
Saihua Huang
XHXiao Han
Xiao Han
CZCaiyan Zhang
Caiyan Zhang
LYLan Yang
Lan Yang
YZYufeng Zhou
Yufeng Zhou

29 September 2020 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
LYLan Yang
Lan Yang
XHXiao Han
Xiao Han
CZCaiyan Zhang
Caiyan Zhang
CSChengjun Sun
Chengjun Sun
SHSaihua Huang
Saihua Huang
YZYufeng Zhou
Yufeng Zhou
Circular RNAs (circRNAs) constitute a class of covalently circular non-coding RNA molecules formed by 5′ and 3′ end back-splicing. The rapid development of bioinformatics and large-scale sequencing has led to the identification of functional circRNAs. Despite an overall upward trend, studies focusing on the roles of circRNAs in immune diseases remain relatively scarce. In the present study, we obtained a differential circRNA expression profile based on microarray analysis of peripheral blood mononuclear cells (PBMCs) in children with type 1 diabetes mellitus (T1DM). We characterized one differentially expressed circRNA back-spliced from the MYB Proto-Oncogene Like 2 (MYBL2) gene in patients with T1DM, termed as hsa_circ_0060450. Subsequent assays revealed that hsa_circ_0060450 can serve as the sponge of miR-199a-5p, release its target gene, Src homology 2 (SH2)-containing protein tyrosine phosphatase 2 (SHP2), encoded by the tyrosine-protein phosphatase non-receptor type 11 gene (PTPN11), and further suppress the JAK-STAT signaling pathway triggered by type I interferon (IFN-I) to inhibit macrophage-mediated inflammation, which indicates the important roles of circRNAs in T1DM and represents a promising therapeutic molecule in the treatment of T1DM.

1 June 2020 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
SHSaihua Huang
Saihua Huang
PXPing Xue
Ping Xue
XHXiao Han
Xiao Han
CZCaiyan Zhang
Caiyan Zhang
LYLan Yang
Lan Yang
YZYufeng Zhou
Yufeng Zhou
Exosomes are an important carrier for cell communication. miRNAs in exosomes are potential biomarkers and therapeutic targets in different types of cancer. However, the role of exosomal miRNAs in medulloblastoma (MB) patients is largely unknown. In this study, we reported that there was a higher level of miR-130b-3p in exosomes derived from MB patient plasma compared with exosomes from healthy control plasma. Exosomes from MB patient plasma could transfer miR-130b-3p to an MB cell line and played suppressor roles for cell proliferation. miR-130b-3p suppressed MB tumorigenesis by targeting a previously unknown target, serine/threonine-protein kinase 1 (SIK1), through the p53 signaling pathways. In addition, we found an unreported role of SIK1 in promoting MB tumor growth and an SIK1 inhibitor could inhibit MB cell proliferation. This research provides new insight into the molecular mechanism of MB and may provide a new therapeutic strategy for MB treatment.